There are no files associated with this item.
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.citation.number | 2 | - |
dc.citation.startPage | 2302121 | - |
dc.citation.title | ADVANCED HEALTHCARE MATERIALS | - |
dc.citation.volume | 13 | - |
dc.contributor.author | Karmacharya, Mamata | - |
dc.contributor.author | Kumar, Sumit | - |
dc.contributor.author | Choi, Yoon Jeong | - |
dc.contributor.author | Cho, Yoon-Kyoung | - |
dc.date.accessioned | 2023-12-21T11:42:06Z | - |
dc.date.available | 2023-12-21T11:42:06Z | - |
dc.date.created | 2023-11-24 | - |
dc.date.issued | 2024-01 | - |
dc.description.abstract | Platelets have shown promise as a means to combat bacterial infections, fostering the development of innovative therapeutic approaches. However, several challenges persist, including cargo loading issues, limited efficacy against biofilms, and concerns regarding the impact of payloads on the platelet carriers. Here, human platelet membrane vesicles (h-PMVs) encapsulating supramolecular metal catalysts (SMCs) as “nanofactories” to convert prodrugs into antimicrobial compounds within close proximity to bacteria are introduced. Having established the feasibility and effectiveness of the SMCs within h-PMVs, referred to as the PLT-reactor, to activate pro-antibiotic drugs (pro-ciprofloxacin and pro-moxifloxacin) using model organisms (Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923), the investigation is subsequently extended to oral biofilms, with a particular emphasis on Streptococcus mutans 3065. This “bind and kill” strategy demonstrates the potent antimicrobial specificity of the PLT-reactor through localized antibiotic production. h-PMVs play a pivotal role by enabling precise targeting of pathogenic biofilms on natural teeth while minimizing potential hemolytic effects. The finding indicates that platelet membrane-cloaked surfaces exhibit robust, multifaceted, and pathogen-specific binding affinity with excellent biocompatibility, making them a promising alternative to antibody-based therapies for infectious diseases. | - |
dc.identifier.bibliographicCitation | ADVANCED HEALTHCARE MATERIALS, v.13, no.2, pp.2302121 | - |
dc.identifier.doi | 10.1002/adhm.202302121 | - |
dc.identifier.issn | 2192-2640 | - |
dc.identifier.scopusid | 2-s2.0-85175864043 | - |
dc.identifier.uri | https://scholarworks.unist.ac.kr/handle/201301/66235 | - |
dc.identifier.wosid | 001095622700001 | - |
dc.language | 영어 | - |
dc.publisher | Wiley | - |
dc.title | Platelet Membrane‐Enclosed Bioorthogonal Catalysis for Combating Dental Caries | - |
dc.type | Article | - |
dc.description.isOpenAccess | FALSE | - |
dc.relation.journalWebOfScienceCategory | Engineering, Biomedical;Nanoscience & Nanotechnology;Materials Science, Biomaterials | - |
dc.relation.journalResearchArea | Engineering;Science & Technology - Other Topics;Materials Science | - |
dc.type.docType | Article | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.subject.keywordAuthor | bioorthogonal catalysis | - |
dc.subject.keywordAuthor | dental caries | - |
dc.subject.keywordAuthor | nanoreactors | - |
dc.subject.keywordAuthor | oral biofilms | - |
dc.subject.keywordAuthor | platelet membranes | - |
dc.subject.keywordPlus | ORAL MICROBIOTA | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordPlus | EXPRESSION | - |
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Tel : 052-217-1404 / Email : scholarworks@unist.ac.kr
Copyright (c) 2023 by UNIST LIBRARY. All rights reserved.
ScholarWorks@UNIST was established as an OAK Project for the National Library of Korea.